What is the difference between BPC-157 and TB-500 for recovery?

While both peptides support healing and angiogenesis, they work through different biological pathways. BPC-157 increases VEGF receptors and growth hormone sensitivity, potentially working better for localized injuries like tendons and gut tissue, while TB-500 regulates actin dynamics and functions more systemically for broader tissue health. BPC-157 has a shorter half-life requiring more frequent dosing, whereas TB-500 has a longer half-life. Research suggests they may have complementary mechanisms, though human clinical data for both remains limited.